Remove 2024 Remove Patient Care Remove Pharmaceutical Companies
article thumbnail

RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals

Pharmaceutical Technology

It will take a regulatory framework that makes sure that the [therapies] that do advance for patient care are the ones that are actually safe and have excellent evidence behind them,” he added.

article thumbnail

A framework for cost-effective and sustainable drug use in hospitals

Hospital Pharmacy Europe

Conducted at Erasmus University Medical Centre in Rotterdam, Netherlands, this research developed a systematic framework known as the 8-Step Efficiency Model to identify and implement medicines cost-saving strategies while maintaining high standards of patient care. 2024 Dec 19. Reference Zietse M, et al.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medical Writing in Enhancing Healthcare Communication

Viseven

In an era where accurate and timely information can critically impact patient outcomes, effective communication in healthcare becomes paramount. Medical writers, thus, serve as key intermediaries between researchers, pharmaceutical companies, and the broader medical community. Scary thought, right? billion by 2032.

article thumbnail

Influence of 5G on Healthcare

Viseven

This marks a significant shift in patient care, as it allows for more accurate diagnoses and a better understanding of which treatments are effective and which are not, compared to relying solely on occasional hospital visits. Future Trends in 5G Network As of 2024, the 5G healthcare market is worth an earth-shattering $85 billion.

article thumbnail

Sandoz targets barriers to biosimilar accessibility with latest initiative

Pharmaceutical Technology

Generic and biosimilar pharmaceutical company and Novartis subsidiary Sandoz announced its plan to accelerate patient access to biosimilars. In a 15 June statement, Sandoz said that it hoped the Act4Biosimilars action plan will provide actionable solutions to overcome barriers preventing patient access to biosimilars.

article thumbnail

Q&A with PQA Board Chair Susan Cantrell

PQA

Susan Cantrell, MHL, RPh, CAE, is PQA’s Board Chair for 2024. She is the Chief Executive Officer of AMCP, the Academy of Managed Care Pharmacy, and has been a member of the PQA Board since 2021. This diversity is what makes PQA work so well on behalf of the patients we all serve. PQA is unique in this space.

article thumbnail

AI in Life Sciences: Exploring Innovation and Opportunities

Viseven

In 2024 , the top 20 pharmaceutical companies have already announced that they are actively researching uses for AI in R&D. Life sciences companies can use AI to analyze vast amounts of data and identify drug targets, design small molecules, generate synthesis pathways for chemical compounds, and predict drug properties.